Store

Home | Store | COVID-19 Testing Market Update, 2022

COVID-19 Testing Market Update, 2022

Publication Date: April 19, 2022

SKU: 22-026

Tags: COVID-19, Infectious Diseases, Pharmaceuticals, Vaccines

Pages: 65

SKU: 22-026

Gain valuable insights into the evolving COVID-19 testing market with Kalorama Information’s comprehensive report, COVID-19 Testing Market Update, 2022. This report offers detailed market sizing and estimates for various COVID-19 tests and explores the market impacts of the ongoing pandemic. Throughout 2021 and into 2022, the relentless presence of COVID-19 has significantly influenced laboratories and in vitro diagnostic (IVD) companies, with testing expanding from large labs and clinics to home environments, boosting market revenues.

Diagnostics have been crucial in the response to COVID-19, underscoring the need for rapid and accurate testing to manage the pandemic effectively. The report anticipates continued investment in diagnostic systems, driven by the pandemic’s lessons and the importance of testing. The forecasted market analysis through 2027 considers demographic trends, new developments, the trajectory of COVID-19 and its variants, innovative technology, and global use.

 

Key Market Data:

  • Test Types: The report breaks down market share by test type, including antigen, PCR, antibody, and point-of-care tests.
  • Forecasts: While there is some uncertainty in exact forecasting, the report provides estimates and projections for the market through 2027.

 

Segmentation and Analysis: Our report includes comprehensive segmentation and breakout analysis, highlighting:

  • Company Market Share: Competitive analysis of the top ten market participants.
  • Trends and Innovations: Examination of market trends, products, and recent test innovations.
  • Regional Breakdown: Detailed regional analysis covering North America, Europe, Asia-Pacific, and the Rest of the World.

 

Market Segmentation by Test Method:

  • Immunoassay Antigen Tests: Used for identifying infected individuals and confirming safety for social interactions.
  • Molecular PCR Tests: The most sensitive COVID-19 diagnostic tests, recommended by WHO for confirming diagnoses in symptomatic individuals.
  • Immunoassay Antibody Tests: Provide information on individual protection through vaccination or previous infection.

 

Table: Global Lab-based COVID-19 Testing Market, Distribution of Sales by Segment, 2022-2027 (in millions $)

Segment Sales 2022 % Mkt Sales 2027 % Mkt
Immunoassay $XX Million XX% $XX Million XX%
Molecular $XX Million XX% $XX Million XX%
Total, Lab-based COVID-19 Market $XX Million XX% $XX Million XX%

Source: Kalorama Information

For further details and to purchase directly, please contact us.

Table of Contents

Chapter 1: Executive Summary

COVID-19 Testing Market Demand and Growth

  • Figure 1-1: COVID Market 2020 vs. 2021, ($billions)
  • Figure 1-2: COVID Testing by Quarter 2021, ($millions)
  • Figure 1-3: COVID-19 Test Market by Type, Q1-Q4 2021 Trend (Serology, Antigen, Molecular, Rapid) ($millions)

Growth Outlook

  • Figure 1-4: Growth Outlook for COVID-19 Testing, 2021 -2023 (percent)

Country Distribution

  • Figure 1-5: COVID-19 Revenue by Country, 2021

Test Innovations and Approvals

  • Table 1-1: Recent COVID-19 Test Approvals and Innovations

 

Chapter 2: Trends and Developments

Antigen and Molecular Product Developments

Antigen

Molecular

Other Developments

COVID-19 Testing Expands Multiplex Testing

COVID-19 Drives Molecular Point of Care Growth

AI Mines CT,  Lab Results to Predict COVID-19 Severity

Long COVID Can Be Predicted Early On

Spectroscopy Employed in COVID-19

 

Chapter 3: Market Analysis COVID Testing

Market Analysis: Molecular, Antigen, Antibody and Rapid Tests

Table 3-1: COVID-19 Product Sales by Type — Immunoassay, Molecular, Rapid [at home, professional POC], 2021 ($ millions)

COVID-19 Test Market Share

  • Figure 3-1: COVID-19 Testing Market Share, 2021

COVID-19 Test Market by Country

  • Table 3-2: COVID-19 Market by Country  (India, China, UK, Germany, Spain, Italy, France, Mexico

US, Canada, Japan, Africa / Middle East, Rest of World)

 

Chapter 4: Top IVD Market Participants

Abbott Laboratories

  • Table 4-1: Abbott Corporate Summary
  • Figure 4-1: Abbott Diagnostics Revenue by Segment (Core Laboratory, Molecular, Point-of-Care, Rapid Diagnostics, COVID-19, BinaxNOW/ID NOW) Full Year, 2020 and 2021
  • Figure 4-2: COVID-19 Distribution of Diagnostic Test Sales, Abbott Laboratories
  • Table 4-2: COVID-19 Test Sales, Abbott Laboratories

Becton Dickinson

  • Table 4-3: Becton Dickinson Corporate Summary

bioMérieux SA

  • Table 4-4: bioMérieux Corporate Summary
  • Figure 4-3: bioMérieux Clinical Applications Segment, Full Year Results, 2020,2021

Danaher Corporation

  • Table 4-5: Danaher Corporation Summary

Recent Results

  • Figure 4-4: Danaher Diagnostic Segment Performance, Full Year Results, 2020,2021

Hologic, Inc.

  • Table 4-6: Hologic Corporate Summary

Recent Results

  • Figure 4-5: Hologic Diagnostic Segment Performance, Full Year Results, FY 2020, FY 2021, $M

Qiagen

  • Table 4-7: Qiagen Corporate Summary

Recent Results

  • Figure 4-6: QIAGEN Revenue Mix Distribution by Business Segment (Molecular Diagnostics, Life Sciences), Q3 2021
  • Figure 4-7: QIAGEN Sales by Product Group (Sample Technologies, Diagnostic Solutions, PCR/Nucleic Acid Amplification, Genomics/NGS, Other), Q3 2021 ($ millions)

Quidel Corporation

  • Table 4-8: Quidel Corporate Summary

Recent Results

  • Figure 4-8: Quidel Corporation Revenue by Product Group, Full Year Results 2020, 2021, $M

Roche Diagnostics

  • Table 4-9: Roche Diagnostic Corporate Summary

Recent Results

  • Figure 4-9: Roche Diagnostics Revenue by Product Group, Full Year Results, 2020, 2021, CHF MN
  • Figure 4-10: Roche COVID-19 Testing by Segment (PCR, Antigen & Serology), Quarterly Reports, 2020 and 2021

Siemens Healthineers

  • Table 4-10: Siemens Healthineers Corporate Summary

Recent Results

  • Figure 4-11: Siemens Diagnostics Revenue, FY 2020 and FY 2021, € MN

Thermo Fisher Scientific

  • Table 4-11: Thermo Fisher Scientific Corporate Summary

Recent Results

  • Figure 4-12: Thermo Fisher Scientific COVID-19 Response Revenue, 2020 and 2021 by Quarter

COVID-19 Test Providers

  • Table 4-12: Test Companies with an EUA-Issued COVID-19 Test (Company, Location, Test Product, Date EUA)

Our Knowledge Center provides access to

all market reports